Gur Roshwalb

2015

In 2015, Gur Roshwalb earned a total compensation of $7.3M as Chief Executive Officer at Akari Therapeutics Plc, a 1,680% increase compared to previous year.

Compensation breakdown

Bonus$86,625
Option Awards$6,863,034
Salary$357,292
Total$7,306,951

Roshwalb received $6.9M in option awards, accounting for 94% of the total pay in 2015.

Roshwalb also received $86.6K in bonus and $357.3K in salary.

Rankings

In 2015, Gur Roshwalb's compensation ranked 912th out of 13,638 executives tracked by ExecPay. In other words, Roshwalb earned more than 93.3% of executives.

ClassificationRankingPercentile
All
912
out of 13,638
93rd
Division
Manufacturing
317
out of 5,190
94th
Major group
Chemicals And Allied Products
117
out of 1,854
94th
Industry group
Drugs
90
out of 1,528
94th
Industry
Pharmaceutical Preparations
74
out of 1,182
94th
Source: SEC filing on April 28, 2016.

Roshwalb's colleagues

We found three more compensation records of executives who worked with Gur Roshwalb at Akari Therapeutics Plc in 2015.

2015

Clive Richardson

Akari Therapeutics Plc

Chief Operating Officer

2015

Dov Elefant

Akari Therapeutics Plc

Chief Financial Officer

2015

Pablo Jimenez

Akari Therapeutics Plc

Chief Medical Officer

In-depth

You may also like